Richard H. Hughes, IV, Member of the Firm in the Health Care & Life Sciences practice, in the firm’s Washington, DC, office, was quoted in Axios, in “Funding Freeze Rollback Further Confuses Health Providers and Researchers.” (Read the full version – subscription required.)
Following is an excerpt:
Health providers and researchers got a reprieve of sorts on Wednesday when the White House rescinded a memo that froze many federal funding sources. But the turnabout didn't entirely make clear what happens next.
The big picture: The whiplash from President Trump's executive orders and directives over the first week and a half of his term portends a tense four years for a heavily regulated sector that's very dependent on federal funding.
"I think across the board you're going to see some trepidation and uncertainty about how to go about continuing important scientific research, among so many other activities," Richard Hughes, a lawyer at Epstein Becker Green, wrote in an email after the memo was rescinded.